{"transactions":[{"id":950005,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T20:26:27.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20400,"derivative":{"exercise_price":35.42,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":20400},"source":{"system":"sec-edgar","filing":"0001193125-26-003111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000119312526003111/ownership.xml","form_type":"4"}},{"id":950004,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-05T20:26:27.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2024 Equity Incentive Plan. All shares subject to the RSU shall vest on the one year anniversary of the grant date of the award."}],"balance_after":51115,"source":{"system":"sec-edgar","filing":"0001193125-26-003111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000119312526003111/ownership.xml","form_type":"4"}},{"id":1309714,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-06T20:14:08.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":18800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18800,"derivative":{"exercise_price":41.12,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":18800},"source":{"system":"sec-edgar","filing":"0000950170-25-002484","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000095017025002484/ownership.xml","form_type":"4"}},{"id":1370846,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-08T18:22:28.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":5.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000950170-24-124296","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000095017024124296/ownership.xml","form_type":"4"}},{"id":1370845,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-11-08T18:22:28.000Z","date":"2024-11-08","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":68.6667,"value":137333.4,"ownership":{"direct":true},"balance_after":47965,"source":{"system":"sec-edgar","filing":"0000950170-24-124296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000095017024124296/ownership.xml","form_type":"4"}},{"id":1370844,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-11-08T18:22:28.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":5.8,"value":11600.0,"ownership":{"direct":true},"balance_after":49965,"source":{"system":"sec-edgar","filing":"0000950170-24-124296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000095017024124296/ownership.xml","form_type":"4"}},{"id":1686960,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T21:24:41.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32000,"derivative":{"exercise_price":18.28,"exercise_date":"2025-01-02","expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001209191-24-000922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919124000922/doc4.xml","form_type":"4"}},{"id":1886445,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-18T18:30:37.000Z","date":"2023-05-16","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":1.19,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-23-030794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123030794/doc4.xml","form_type":"4"}},{"id":1886444,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-05-18T18:30:37.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":16000,"price":24,"value":384000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":47965,"source":{"system":"sec-edgar","filing":"0001209191-23-030794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123030794/doc4.xml","form_type":"4"}},{"id":1886443,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-05-18T18:30:37.000Z","date":"2023-05-16","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":1.19,"value":19040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":63965,"source":{"system":"sec-edgar","filing":"0001209191-23-030794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123030794/doc4.xml","form_type":"4"}},{"id":1914757,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-24T19:31:25.000Z","date":"2023-04-24","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":3.33,"exercise_date":"2017-01-04","expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-23-025473","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123025473/doc4.xml","form_type":"4"}},{"id":1914756,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-24T19:31:25.000Z","date":"2023-04-24","kind":"sale","planned":false,"acquired":false,"shares":16000,"price":22.0038,"value":352060.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":47965,"source":{"system":"sec-edgar","filing":"0001209191-23-025473","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123025473/doc4.xml","form_type":"4"}},{"id":1914755,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-24T19:31:25.000Z","date":"2023-04-24","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":3.33,"value":53280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":63965,"source":{"system":"sec-edgar","filing":"0001209191-23-025473","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123025473/doc4.xml","form_type":"4"}},{"id":1917852,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-18T19:10:09.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":20786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option vested on May 26, 2016, the date of the Issuer's first Annual Meeting of Stockholders following the date of grant."}],"balance_after":0,"derivative":{"exercise_price":8,"exercise_date":"2016-05-26","expiration_date":"2025-04-28","underlying":"Common Stock","underlying_shares":20786},"source":{"system":"sec-edgar","filing":"0001209191-23-024725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123024725/doc4.xml","form_type":"4"}},{"id":1917851,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-18T19:10:09.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":20786,"price":20,"value":415720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":47965,"source":{"system":"sec-edgar","filing":"0001209191-23-024725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123024725/doc4.xml","form_type":"4"}},{"id":1917850,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-18T19:10:09.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":true,"shares":20786,"price":8,"value":166288.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":68751,"source":{"system":"sec-edgar","filing":"0001209191-23-024725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123024725/doc4.xml","form_type":"4"}},{"id":2065706,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T18:11:59.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":8.52,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-23-001311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919123001311/doc4.xml","form_type":"4"}},{"id":2442778,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T19:09:24.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":4.88,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-22-001981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919122001981/doc4.xml","form_type":"4"}},{"id":2914618,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T16:41:52.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":5.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-21-002135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919121002135/doc4.xml","form_type":"4"}},{"id":3321400,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T19:57:49.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":7.95,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-20-001420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919120001420/doc4.xml","form_type":"4"}},{"id":3707325,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T20:22:33.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22000,"derivative":{"exercise_price":8.32,"exercise_date":"2020-01-02","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-19-001561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919119001561/doc4.xml","form_type":"4"}},{"id":3912008,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2018-05-31T18:57:36.000Z","date":"2018-05-29","kind":"purchase","acquired":true,"shares":47965,"price":5.219,"value":250329.335,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.1417 to $5.2412, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":47965,"source":{"system":"sec-edgar","filing":"0001209191-18-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919118034482/doc4.xml","form_type":"4"}},{"id":4110334,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-03T16:16:24.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":4.48,"exercise_date":"2019-01-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-18-000840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919118000840/doc4.xml","form_type":"4"}},{"id":4497649,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":70256,"kind":"person","name":"MACARTNEY LAWSON","position":1,"cik":"0001606831","reported_name":"MACARTNEY LAWSON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T19:15:12.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":1.19,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-17-002379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1606831/000120919117002379/doc4.xml","form_type":"4"}}]}